News & Updates

Severe hypoglycaemia may contribute to a higher risk of incident heart failure (HF) among adults with type 2 diabetes (T2D), reports a study.

Immunocompromised patients, particularly those who had undergone organ transplants, show markedly lower seroconversion rates after vaccination against the coronavirus disease 2019 (COVID-19), according to a recent Singapore meta-analysis.

Deucravacitinib, a selective TYK2 inhibitor, is well tolerated and appears to produce marked improvements in American College of Rheumatology 20 (ACR20) and other endpoints in the treatment of patients with psoriatic arthritis (PsA), according to the results of a phase II study.

Patients with irritable bowel syndrome (IBS) are willing to take on significant medication risks in exchange for a permanent cure of their symptoms, a study has found.

Traditional dietary advice, gluten-free diet, and low FODMAP diet are all effective dietary approaches to reducing symptoms in patients with irritable bowel symptom (IBS), but traditional dietary advice is the pick of the bunch in terms of cost and convenience, according to a team of UK-based researchers.

Psoriasis patients treated with ixekizumab show better persistence and adherence over 24 months as well as a lower risk of discontinuation than those using secukinumab, reports a recent study that used real-world data.